Skip to Main Content

Paper Details

The Effect of Perimenopausal Transdermal Estradiol and Micronized Progesterone on Markers of Risk for Arterial Disease.
J Clin Endocrinol Metab
6
2020
Arterial Disease, Estradiol, FMD, IMP, Progesterone, Women, arterial disease, cholesterol, cortisol, estradiol, insulin, low-density lipoprotein cholesterol, metabolic syndrome, progesterone, women
Author NameAffiliation
David R RubinowUniversity of North Carolina at Chapel Hill
Melissa C CaugheyUniversity of North Carolina at Chapel Hill
  • 1 - 2

Datasets